Arbutus Biopharma Corporation DPO Ratio | ABUS

Annual DPO Ratio Arbutus Biopharma Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
-	-	-	-	-	23	15.2	20.1	11.6	19.2	18.5	19.3	20.7	16.2	-	-

All numbers in USD currency

Maximum	Minimum	Average
23	11.6	18.2

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Clovis Oncology CLVS	236	-	-7.23 %	$ 13 M	USA
BioMarin Pharmaceutical BMRN	245	$ 60.26	0.06 %	$ 11.6 B	USA
Catalyst Biosciences CBIO	7.82	$ 13.99	0.84 %	$ 1.25 B	USA
Codexis CDXS	85.8	$ 1.32	1.09 %	$ 115 M	USA
Cerus Corporation CERS	242	$ 2.62	0.38 %	$ 499 M	USA
Coherus BioSciences CHRS	507	$ 1.13	0.43 %	$ 132 M	USA
Celldex Therapeutics CLDX	4.06 K	$ 31.1	1.16 %	$ 2.07 B	USA
CollPlant Biotechnologies Ltd. CLGN	323	$ 4.25	3.16 %	$ 51.9 M	Israel
AbbVie ABBV	65.5	$ 264.34	0.09 %	$ 468 B	USA
Cocrystal Pharma COCP	27	$ 1.17	1.74 %	$ 13.2 M	USA
Abeona Therapeutics ABEO	1.35 K	$ 5.4	2.65 %	$ 286 M	USA
Collegium Pharmaceutical COLL	34.6	$ 22.53	0.2 %	$ 713 M	USA
Corcept Therapeutics Incorporated CORT	785	$ 116.1	4.93 %	$ 12.1 B	USA
Фармсинтез LIFE	306	-	-	-	Russia
Cardiff Oncology CRDF	406	$ 1.24	0.74 %	$ 82.9 M	USA
Curis CRIS	3.24 K	$ 0.83	1.1 %	$ 10.9 M	USA
CorMedix CRMD	79.3	$ 7.85	1.03 %	$ 565 K	USA
Crinetics Pharmaceuticals CRNX	4.83 K	$ 84.95	0.13 %	$ 7.99 B	USA
Champions Oncology CSBR	65.9	$ 4.9	0.1 %	$ 67.8 M	USA
Chimerix CMRX	2.38 K	-	-	$ 756 M	USA
Daré Bioscience DARE	1.64 K	$ 0.78	4.73 %	$ 8.72 M	USA